Latest News

Newly identified antibodies effectively treat Alzheimer's-like disease in mice

Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified antibody treatments can prevent the accumulation of one of these of these toxic components, called tau proteins. The findings suggest that these antibodies may provide a basis for a promising therapy for patients with Alzheimer's disease and other neurodegenerative disorders.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • E-cigarettes significantly reduce tobacco cravings, study suggests

  • Coping strategies therapy significantly improves dementia carers' mental health, quality of life

  • Fathers' engagement with baby depends on mother

  • Unstable child care can affect children by age four

  • Self-regulation intervention boosts school readiness of at-risk children, study shows

  • Rejecting unsuitable suitors is easier said than done

  • Reported opioid abuse in pregnant women more than doubles in 14 years

  • Computerized cognitive training has modest benefits for cognitively healthy older adults

  • Gamification for behavior change: What is it and how is it useful?

  • Spatial memory: Orientation study suggests that a visual image of the intermediate spatial environment exists in brain

  •